ProKidney Corp.
PROK
$1.67
-$0.04-2.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 889.00K | 893.00K | 744.00K | 527.00K | 306.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 889.00K | 893.00K | 744.00K | 527.00K | 306.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 889.00K | 893.00K | 744.00K | 527.00K | 306.00K |
| SG&A Expenses | 48.74M | 51.78M | 51.89M | 52.67M | 52.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 169.44M | 165.90M | 171.63M | 176.84M | 179.97M |
| Operating Income | -168.55M | -165.01M | -170.89M | -176.32M | -179.66M |
| Income Before Tax | -156.46M | -151.20M | -155.54M | -163.65M | -166.06M |
| Income Tax Expenses | -177.00K | 414.00K | 3.70M | 799.00K | -105.00K |
| Earnings from Continuing Operations | -156.28 | -151.61 | -159.24 | -164.45 | -165.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 83.99M | 82.63M | 88.21M | 91.98M | 97.53M |
| Net Income | -72.29M | -68.99M | -71.03M | -72.47M | -68.43M |
| EBIT | -168.55M | -165.01M | -170.89M | -176.32M | -179.66M |
| EBITDA | -161.92M | -158.43M | -164.58M | -170.19M | -173.73M |
| EPS Basic | -0.53 | -0.52 | -0.55 | -0.57 | -0.60 |
| Normalized Basic EPS | -0.10 | -0.09 | -0.07 | -0.05 | -0.01 |
| EPS Diluted | -0.53 | -0.52 | -0.55 | -0.57 | -0.60 |
| Normalized Diluted EPS | -0.10 | -0.09 | -0.07 | -0.05 | -0.01 |
| Average Basic Shares Outstanding | 548.65M | 533.70M | 520.91M | 512.09M | 457.27M |
| Average Diluted Shares Outstanding | 548.65M | 533.70M | 520.91M | 512.09M | 457.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |